GB
Govindaraju Bhavani
About Govindaraju Bhavani
Data last updated:
Govindaraju Bhavani is a Director at Hetero Labs Limited (since 2023), Director at Annora Pharma Private Limited (since 2022) and Director at Hetero Biopharma Limited (since 2022). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹18,418 Cr; the largest is Hetero Labs Limited at ₹16,537 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hetero Labs Limited U24110TG1989PLC009723 | Director | 11 Aug 2023 | 1989 | ₹16,537 Cr (FY 2025) | Active |
 Annora Pharma Private Limited U24100TG2015PTC101939 | Director | 30 Jun 2022 | 2015 | ₹1,494 Cr (FY 2025) | Active |
| Hetero Biopharma Limited U24290TG2016PLC111946 | Director | 26 Aug 2022 | 2016 | ₹387 Cr (FY 2024) | Active |
Board colleagues of Govindaraju Bhavani
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Govindaraju Bhavani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Govindaraju Bhavani
Govindaraju Bhavani currently holds 3 directorships: Hetero Labs Limited (Director, since 11 Aug 2023, revenue ₹16,537 Cr (FY 2025)); Annora Pharma Private Limited (Director, since 30 Jun 2022, revenue ₹1,494 Cr (FY 2025)); Hetero Biopharma Limited (Director, since 26 Aug 2022, revenue ₹387 Cr (FY 2024)).
Govindaraju Bhavani was first appointed on 30 Jun 2022 as Director at Annora Pharma Private Limited. The most recent appointment on record is 11 Aug 2023 at Hetero Labs Limited.
The 3 current companies of Govindaraju Bhavani that report revenue have a combined latest revenue of ₹18,418 Cr: Hetero Labs Limited ₹16,537 Cr (FY 2025); Annora Pharma Private Limited ₹1,494 Cr (FY 2025); Hetero Biopharma Limited ₹387 Cr (FY 2024).
The current boards of Govindaraju Bhavani's companies include Attunuri Venkatanarasa Reddy (Hetero Labs Limited), Bandi Vamsikrishna (Hetero Labs Limited), Kiran Kumar Manikwar (Hetero Labs Limited), Kshitiz Gadodia (Hetero Labs Limited), Mohana Reddy Chilukuri (Hetero Labs Limited), Parthasaradhi Reddy Bandi (Hetero Labs Limited), among others.